Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Cornification is the process where living skin cells die to create a protective barrier, and problems with it can cause skin diseases.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

MicroRNAs can help regenerate hair by influencing stem cells and immune responses, but delivery challenges exist.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Ongoing research and innovation are crucial for improving skin care and treatment.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

The model and estimator can predict drug exposure in kidney transplant patients well.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

New treatments offer hope for better managing hidradenitis suppurativa.

The document is a detailed medical reference on skin and genetic disorders.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.